Kornblau SM - Search Results

1

Recognition of Recurrent Protein Expression Patterns in Pediatric Acute Myeloid Leukemia Identified New Therapeutic Targets.

Hoff FW, Hu CW, Qiu Y, Ligeralde A, Yoo SY, Mahmud H, de Bont ESJM, Qutub AA, Horton TM, Kornblau SM. Hoff FW, et al. Among authors: kornblau sm. Mol Cancer Res. 2018 Aug;16(8):1275-1286. doi: 10.1158/1541-7786.MCR-17-0731. Epub 2018 Apr 18. Mol Cancer Res. 2018. PMID: 29669821 Free PMC article.

2

Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia.

Kornblau SM, Xu HJ, del Giglio A, Hu SX, Zhang W, Calvert L, Beran M, Estey E, Andreeff M, Trujillo J, et al. Kornblau SM, et al. Cancer Res. 1992 Sep 1;52(17):4587-90. Cancer Res. 1992. PMID: 1511426

3

Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia.

Anderlini P, Benjamin RS, Wong FC, Kantarjian HM, Andreeff M, Kornblau SM, O'Brien S, Mackay B, Ewer MS, Pierce SA, et al. Anderlini P, et al. Among authors: kornblau sm. J Clin Oncol. 1995 Nov;13(11):2827-34. doi: 10.1200/JCO.1995.13.11.2827. J Clin Oncol. 1995. PMID: 7595745

4

Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia.

Kornblau SM, Xu HJ, Zhang W, Hu SX, Beran M, Smith TL, Hester J, Estey E, Benedict WF, Deisseroth AB. Kornblau SM, et al. Blood. 1994 Jul 1;84(1):256-61. Blood. 1994. PMID: 8018920 Free article.

5

Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia.

Kornblau SM, Chen N, del Giglio A, O'Brien S, Deisseroth AB. Kornblau SM, et al. Cancer Res. 1994 Jan 1;54(1):242-6. Cancer Res. 1994. PMID: 8261446

6

Ratio of bcl-xshort to bcl-xlong is different in good- and poor-prognosis subsets of acute myeloid leukemia.

Deng G, Lane C, Kornblau S, Goodacre A, Snell V, Andreeff M, Deisseroth AB. Deng G, et al. Mol Med. 1998 Mar;4(3):158-64. Mol Med. 1998. PMID: 9562974 Free PMC article.

7

Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study.

Kornblau SM, Andreeff M, Hu SX, Xu HJ, Patel S, Theriault A, Koller C, Kantarjian H, Estey E, Deisseroth AB, Benedict WF. Kornblau SM, et al. Clin Cancer Res. 1998 Aug;4(8):1955-63. Clin Cancer Res. 1998. PMID: 9717825

8

Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia.

Estrov Z, Thall PF, Talpaz M, Estey EH, Kantarjian HM, Andreeff M, Harris D, Van Q, Walterscheid M, Kornblau SM. Estrov Z, et al. Among authors: kornblau sm. Blood. 1998 Nov 1;92(9):3090-7. Blood. 1998. PMID: 9787143 Free article.

9

High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia.

Zhang W, Kornblau SM, Kobayashi T, Gambel A, Claxton D, Deisseroth AB. Zhang W, et al. Among authors: kornblau sm. Clin Cancer Res. 1995 Sep;1(9):1051-7. Clin Cancer Res. 1995. PMID: 9816079

10

The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics.

Kornblau SM, Thall PF, Estrov Z, Walterscheid M, Patel S, Theriault A, Keating MJ, Kantarjian H, Estey E, Andreeff M. Kornblau SM, et al. Clin Cancer Res. 1999 Jul;5(7):1758-66. Clin Cancer Res. 1999. PMID: 10430080

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

356 results

Search Page

Filters